跳至主要内容
临床试验/NL-OMON29996
NL-OMON29996撤回3 期

Transurethral Ultrasound directed Injection of autologous Myoblasts, Fibroblasts and Collagen for the treatment of urinary incontinence - Urocell in urinary incontinence

Innovacell Biotechnologie GmbH0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
撤回
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Age 18-70 years
  • * Verified diagnosis of urinary incontinence
  • * Stress- or mixed urinary incontinence (without severe descensus of pelvic organs or dominant urgency complaints)

排除标准

  • * A neurological disorder as the sole reason for the incontinence
  • * Women with marked descensus of the pelvic organs or marked hypermobility of the urethra
  • *Pregnancy
  • * Allergy against collagen
  • * (Planned) treatment with immunosuppressive medication or any immunosupression therapy
  • * Previous X-ray treatment of pelvic organs
  • * Severe autoimmune disease
  • * Bladder instability and/or pure urge incontinence
  • * Lactating patients
  • * Previous treatment with TVT, TOT or bulking agents
  • * Malignancy treated or apt to be treated by x-ray therapy or chemotherapy

研究者

发起方
Innovacell Biotechnologie GmbH

相似试验

Transurethral Ultrasound directed Injection of... | 临床试验